2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

T Cell Responses to Viral Peptide Stimulation Predict Influenza Vaccine-Induced Seroconversion in Pediatric Solid Organ Transplant Recipients.

E. Mayer,¹ M. Altrich,² C. Cordes,² S. Fausett,² J. Tepp,³ R. Albrecht,³ A. Fernandez-Sesma,³ B. Herold,¹ I. Ramos,³ R. Madan.¹
T-Cell Aging Parameters in the Lymph Node and Peripheral Blood Are Strongly Associated but Terminally Differentiated T Cells Are Mainly Located within the Circulation.

B. Dedeoglu,¹ A. de Weerd,¹ L. Huang,¹ A. Langerak,² M. Klepper,¹ W. Verschoor,¹ D. Reijerkerk,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹
T_FR:T_FH Cell Ratio Correlates with Anti-Donor Germinal Center Reactivity and Donor-Specific Antibody Formation Following Transplantation.

G. La Muraglia II, M. Ford, I. Badell.
TACI Polymorphisms Associated with De Novo Alloantibodies in Humans and Allograft Rejection in Mice.

J. Platt,¹ E. Farkash,² A. Lefferts,¹ M. Samaniego,³ M. Cascalho.¹
Tacrolimus and Mycophenolate Exposure and Subclinical Tubulo-Interstitial Inflammation in Low Immunological Risk Renal Transplants.

I. Torres,¹ A. Reisaeter,² F. Moreso,¹ A. Asberg,² M. Perello,¹ C. Dörje,² J. Sellares,¹ K. Midtved,² H. Holdaas,² D. Seron.¹
Tacrolimus and Mycophenolic Acid Have a Limited Inhibitory Effect on Monocyte Signaling Pathway Phosphorylation, Function and Differentiation.

N. Kannegieter,¹ D. Hesselink,¹ M. Dieterich,¹ R. Kraaijeveld,¹ A. Rowshani,¹ P. Leenen,² C. Baan.¹
Tacrolimus Appears to Be a Protective Factor for De Novo DSA Formation in Non-Sensitized Kidney Transplant Patients.

M. Marron-Wojewodzki,¹ I. Szwarc,¹ C. Rene,² G. Mourad,¹ M. Le Quintrec.^1,3
Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients.

L. Qu, Z. Xie, H. Huang, H. Jiang, J. Chen, H. Jiang, H. Jiang, J. Chen, J. Chen, J. Chen.
Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients.

S. Seibert,¹ D. Schladt,² B. Wu,³ W. Guan,³ C. Dorr,^2,7 D. Berglund,¹ R. Remmel,⁴ A. Matas,⁵ R. Mannon,⁶ A. Israni,^2,7 W. Oetting,¹ P. Jacobson,¹ For the DeKAF Genomics Investigators.
Tacrolimus Intra-Patient Variability Determined from Daily Trough Levels in Adherent Kidney and Liver Transplant Recipients.

A. Leino,¹ T. Kaiser,¹ Y. Zou,² E. King,² A. Vinks,² W. Jiang,⁴ U. Christians,³ E. Woodle,¹ R. Alloway.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z